XML 26 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements Of Cash Flows - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Activities    
Net loss $ (100,943) $ (18,455)
 Items not requiring cash and cash equivalents:    
Depreciation and amortization 128,287 87,622
Equity earnings from associates and joint ventures (4,719) (671)
Deferred income taxes (Note 21) 3,265 43,422
Share-based compensation expense (Note 25) 16,162 12,937
Gain on disposal of property, plant and equipment (Note 10) (199) (135)
Impairment on property, plant and equipment and energy infrastructure assets (Note 10) 1,233 537
Impairment of goodwill (Note 15) 48,000  
Adjustments to reconcile profit (loss) other than changes in working capital 91,086 125,257
Net change in working capital and other (Note 31) (71,318) 82,937
Cash provided by operating activities 19,768 208,194
Investing Activities    
Net cash acquired from Acquisition (Note 7) 133,218  
Additions to:    
Property, plant and equipment (Note 10) (8,043) (5,154)
Energy infrastructure assets (Note 10) (107,797) (52,187)
Proceeds on disposal of:    
Property, plant and equipment (Note 10) 416 220
Energy infrastructure assets (Note 10) 15,907 4,670
Investment in associates and joint ventures (5,950) (130)
Dividends received from associates and joint ventures 3,094  
Net change in accounts payable related to the addition of property, plant and equipment, and energy infrastructure assets 12,403 3,720
Cash provided by (used in) investing activities 43,248 (48,861)
Financing Activities    
Net proceeds from the Revolving Credit Facility (Note 19) 464,624  
Issuance of the Notes (Note 19) 797,629  
Issuance of the Term Loan (Note 19) 207,062  
Repayment of assumed debt on Acquisition (Note 7) (1,022,112)  
Repayment of the Notes (Note 19) (285,722) (40,000)
Repayment of the Bank Facility (Note 19) (31,213) (53,891)
Net proceeds from (repayment of) the Asset-Based Facility (Note 19) (39,295) 36,916
Dividends (8,969) (7,171)
Lease liability principal repayment (Note 20) (15,758) (14,215)
Stock option exercises (Note 22) 260  
Deferred transaction costs (54,652) (2,095)
Cash provided by (used in) financing activities 11,854 (80,456)
Effect of exchange rate changes on cash and cash equivalents denominated in foreign currencies 6,148 (1,795)
Increase in cash and cash equivalents 81,018 77,082
Cash and cash equivalents, beginning of period 172,758 95,676
Cash and cash equivalents, end of period $ 253,776 $ 172,758